Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis

Nicoletta Del Papa(University of Milan), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Daniele Vincenti(University of Milan), Romina Andracco(Istituto Ortopedico Gaetano Pini), Elena Tagliaferri(University of Milan), Tiziana Montemurro(University of Milan), Francesco Onida(Peter MacCallum Cancer Centre), Giorgia Saporiti(University of Milan), Eleonora Zaccara(Istituto Ortopedico Gaetano Pini), Wanda Maglione(University of Milan), Claudio Vitali, Luca Mircoli(University of Milan)
Bone Marrow Transplantation
August 22, 2016
10.1038/bmt.2016.211
Cited by 72

Related Papers

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373